Fischer Imaging last week tapped a Lorad veteran to fill a newlycreated position designed to focus the Denver company's effortsin breast imaging. John Neugebauer has been appointed directorof breast imaging, according to Fischer chairman and CEO
Fischer Imaging last week tapped a Lorad veteran to fill a newlycreated position designed to focus the Denver company's effortsin breast imaging. John Neugebauer has been appointed directorof breast imaging, according to Fischer chairman and CEO MorganNields.
Neugebauer joins Fischer from Lorad, where he was directorof market development for its Stereoguide biopsy system and wasalso international sales manager. He also has mammography experiencewith CGR and Philips Medical Systems.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
GE HealthCare Unveils Enhanced LesionID Pro at SNMMI Conference
Published: June 21st 2025 | Updated: June 21st 2025Emphasizing a zero-click experience, the updated LesionID Pro software, to be introduced at the SNMMI conference, reportedly provides AI-powered automated insights into whole-body tumor burden with PET and SPECT imaging.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.